#Vaccinationstrategy

In a surprising turn that challenges long-standing public health directives, a study by the Cleveland Clinic has revealed that the influenza vaccine meant to combat the 2024-2025 flu season may have inadvertently increased the risk of infection among recipients. Conducted under the leadership of Dr. Nabin Shrestha, the research analyzed the health records of over 53,000 employees from the clinic’s Ohio locations, finding a 27% higher infection risk for those vaccinated compared to their unvaccinated counterparts source.

A new analysis from the Cleveland Clinic has sparked debate about influenza vaccines for the 2024-2025 season. Led by a senior researcher, the study examined health records of more than 53,000 employees in Ohio and found that those who received the flu shot had a higher observed rate of infection than those who were not vaccinated. The researchers report a 27% increased risk of flu among vaccinated individuals in this cohort, with the vaccine effectiveness estimated at negative 26.9%.